In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci

被引：16

作者：

Fluit, AC ^{[1
]}

Schmitz, FJ ^{[1
]}

Verhoef, J ^{[1
]}

Milatovic, D ^{[1
]}

机构：

[1] UMCU, Eijkman Winkler Ctr, NL-3508 GA Utrecht, Netherlands

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 02期

关键词：

D O I：

10.1093/jac/dkf109

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

AZD2563 is a new oxazolidinone that has targeted activity against Gram-positive bacteria. The in vitro activity of AZD2563 and nine comparators against 1543 European enterococcal, staphylococcal and streptococcal isolates was determined. The compound is a potent oxazolidinone, with no isolate tested displaying an MIC > 4 mg/L and 94.4% having an MIC less than or equal to2 mg/L. Compared with linezolid, the distribution of MICs for all species of bacteria tested, with the exception of Enterococcus faecium, was shifted by one or two dilution steps to lower values for AZD2563. Thus, this oxazolidinone is a promising new antibiotic for the treatment of infections with Gram-positive cocci.

引用

页码：271 / 276

页数：6

共 50 条

[21] Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents
Ednie, LM
Jacobs, MR
Appelbaum, PC
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (01) : 101 - 105
[22] AZD2563, a new oxazolidinone: bactericidal activity and synergy studies combined with gentamicin or vancomycin against staphylococci and streptococcal strains
Jones, RN
Anderegg, TR
Deshpande, LM
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2002, 43 (01) : 87 - 90
[23] In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci
Cilli, F
Aydemir, S
Tunger, A
JOURNAL OF CHEMOTHERAPY, 2006, 18 (01) : 27 - 32
[24] In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece
Malli, E.
Spiliopoulou, I.
Kolonitsiou, F.
Klapsa, D.
Giannitsioti, E.
Pantelidi, K.
Pratti, A.
Panopoulou, M.
Grapsa, S.
Alepopoulou, E.
Neonakis, I.
Frantzidou, F.
Alexiou-Daniel, S.
Bakola, D.
Koutsia-Carouzou, C.
Malamou-Lada, H.
Zerva, L.
Vlahaki, E.
Kartali-Ktenidou, S.
Anastassiou, E. D.
Petinaki, E.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2008, 32 (06) : 525 - 528
[25] INVITRO ACTIVITY OF FOSFOMYCIN AGAINST PROBLEM GRAM-POSITIVE COCCI
HAMILTONMILLER, JMT
MICROBIOS, 1992, 71 (287) : 95 - 103
[26] THE INVITRO ACTIVITY OF RP 59500 AGAINST GRAM-POSITIVE COCCI
GOTO, S
MIYAZAKI, S
KANEKO, Y
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1992, 30 : 25 - 28
[27] In the wings: Ketolides against gram-positive cocci
Gorbach, SL
INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1998, 7 (06) : 249 - 249
[28] In vitro activity of aurein 1.2 alone and in combination with antibiotics against gram-positive nosocomial cocci
Giacometti, Andrea
Cirioni, Oscar
Riva, Alessandra
Kamysz, Wojciech
Silvestri, Carmela
Nadolski, Piotr
Della Vittoria, Agnese
Lukasiak, Jerzy
Scalise, Giorgio
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (04) : 1494 - 1496
[29] Comparative in vitro activity of five macrolides against gram-positive cocci, Campylobacter species, and anaerobes
Marina, M
Ivanova, K
Hadjieva, N
Urumov, A
EXPANDING INDICATIONS FOR THE NEW MACROLIDES, AZALIDES, AND STREPTOGRAMINS, 1997, 21 : 505 - 510
[30] Comparative activities of the oxazolidinone AZD2563 and linezolid against selected recent north American isolates of Streptococcus pneumoniae
Baum, SE
Crawford, SA
McElmeel, ML
Whitney, CG
Jorgensen, JH
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) : 3094 - 3095

← 1 2 3 4 5 →